Integra Lifesciences shares are trading lower after Citigroup and BTIG both downgraded the stock from Neutral to Sell. The company recently lowered its FY24 guidance.
Portfolio Pulse from Benzinga Newsdesk
Integra Lifesciences shares are trading lower after Citigroup and BTIG both downgraded the stock from Neutral to Sell. The company recently lowered its FY24 guidance.
July 30, 2024 | 10:47 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Integra Lifesciences shares are trading lower after Citigroup and BTIG both downgraded the stock from Neutral to Sell. The company recently lowered its FY24 guidance.
The downgrades from Citigroup and BTIG, combined with the lowered FY24 guidance, are likely to negatively impact investor sentiment and put downward pressure on the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100